Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999902 · ClinicalTrials.gov registry record · Phase 2
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)
A Phase 2 study of Focal Seizure, sponsored by Praxis Precision Medicines.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 230
- Enrollment target
- 20
- Study locations
NCT06999902 is a Phase 2 study of Focal Seizure that is actively recruiting participants, run by Praxis Precision Medicines. The registered enrollment target is 230 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT06999902, a Phase 2 study of Focal Seizure, is actively recruiting participants, sponsored by Praxis Precision Medicines.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 230 participants
- Enrollment target
- 20
- Study locations
Study Summary
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)
Conditions Studied
Interventions
- DRUG Placebo
- DRUG 20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks
Study Locations (20)
Texas
- Praxis Research Site - El Paso
- Praxis Research Site - Frisco
- Praxis Research Site - Round Rock
- Praxis Research Site - Seabrook
Other
- Praxis Research Site - Barcelona
- Praxis Research Site - Barcelona
- Praxis Research Site - Barcelona
- Praxis Research Site - Granda
Florida
- Praxis Research Site - DeLand
- Praxis Research Site - Miami Lakes
Missouri
- Praxis Research Site - Chesterfield
- Praxis Research Site - Ozark
Arizona
- Praxis Research Site - Phoenix
Illinois
- Praxis Research Site - Chicago
Louisiana
- Praxis Research Site - Lafayette
Maryland
- Praxis Research Site - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2024-12-11 |
| Est. Completion | 2025-12-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06999902
The ClinicalTrials.gov registry entry for NCT06999902 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Praxis Precision Medicines, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Focal Seizure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06999902 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Texas, Other, Florida.
Frequently Asked Questions
What is clinical trial NCT06999902 about?
NCT06999902 is a clinical study titled "Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)". A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults With Focal Seizures (POWER1)
What is the current status of trial NCT06999902?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 230 participants. The study started on 2024-12-11. Estimated completion is 2025-12-08.
What conditions does trial NCT06999902 study?
This clinical trial studies the following conditions: Focal Seizure.
What interventions are being tested in trial NCT06999902?
The interventions under investigation include: Placebo (DRUG), 20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks (DRUG).
Who is sponsoring clinical trial NCT06999902?
This trial is sponsored by Praxis Precision Medicines, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06999902 being conducted?
This trial has 20 study locations across Arizona, Florida, Illinois, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Focal Seizure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.